Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Journey Medical Corp (DERM)

Journey Medical Corp (DERM)
6.33 +0.08 (+1.28%) 04/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Mon, Apr 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
6.06
Day High
6.45
Open 6.21
Previous Close 6.25 6.25
Volume 39,500 39,500
Avg Vol 102,985 102,985
Stochastic %K 38.59% 38.59%
Weighted Alpha +75.94 +75.94
5-Day Change +0.30 (+4.98%) +0.30 (+4.98%)
52-Week Range 3.20 - 7.29 3.20 - 7.29
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 144,400
  • Shares Outstanding, K 23,104
  • Annual Sales, $ 56,130 K
  • Annual Income, $ -14,670 K
  • EBIT $ -15 M
  • EBITDA $ -11 M
  • 60-Month Beta 0.90
  • Price/Sales 2.56
  • Price/Cash Flow N/A
  • Price/Book 6.86

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.24
  • Number of Estimates 2
  • High Estimate -0.19
  • Low Estimate -0.29
  • Prior Year -0.53
  • Growth Rate Est. (year over year) +54.72%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.51 +14.88%
on 03/27/25
Period Open: 5.74
7.29 -13.17%
on 04/04/25
+0.59 (+10.28%)
since 03/21/25
3-Month
3.54 +79.07%
on 01/22/25
Period Open: 3.74
7.29 -13.17%
on 04/04/25
+2.59 (+69.25%)
since 01/21/25
52-Week
3.20 +97.81%
on 05/21/24
Period Open: 3.48
7.29 -13.17%
on 04/04/25
+2.85 (+81.90%)
since 04/19/24

Most Recent Stories

More News
Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer

FBIO : 1.5000 (-1.96%)
DERM : 6.33 (+1.28%)
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights

FBIO : 1.5000 (-1.96%)
DERM : 6.33 (+1.28%)
Journey Medical Corporation Launches Emrosiâ„¢ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea

FBIO : 1.5000 (-1.96%)
DERM : 6.33 (+1.28%)
Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025

FBIO : 1.5000 (-1.96%)
DERM : 6.33 (+1.28%)
Journey Medical Corporation to Participate in the 37th Annual ROTH Conference

FBIO : 1.5000 (-1.96%)
DERM : 6.33 (+1.28%)
Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosiâ„¢ (DFD-29) to Treat Rosacea

FBIO : 1.5000 (-1.96%)
DERM : 6.33 (+1.28%)
Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida

FBIO : 1.5000 (-1.96%)
DERM : 6.33 (+1.28%)
Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosiâ„¢ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

FBIO : 1.5000 (-1.96%)
DERM : 6.33 (+1.28%)
Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

FBIO : 1.5000 (-1.96%)
DERM : 6.33 (+1.28%)
Journey Medical Corporation Announces U.S. FDA Approval of Emrosiâ„¢ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

FBIO : 1.5000 (-1.96%)
DERM : 6.33 (+1.28%)

Business Summary

Journey Medical Corporation is a commercial-stage pharmaceutical company. It focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Journey Medical Corporation is based in Scottsdale, Arizona.

See More

Key Turning Points

3rd Resistance Point 6.89
2nd Resistance Point 6.67
1st Resistance Point 6.50
Last Price 6.33
1st Support Level 6.11
2nd Support Level 5.89
3rd Support Level 5.72

See More

52-Week High 7.29
Last Price 6.33
Fibonacci 61.8% 5.73
Fibonacci 50% 5.25
Fibonacci 38.2% 4.76
52-Week Low 3.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro